ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Possible Association Between Agent Orange, AML, IOM Says.

April 27, 2001

“Clinical research of all kinds in the IRP lacks a rigorous, centralized process for peer review.”

July 21, 1995

In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick

September 23, 1983

Tamoxifen Trial may EB Funded In Part With CCOP Money

March 22, 1991

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976

NCCS Networker Volume 1 Issue 2, Summer 1987

June 13, 1987